Compare KALA & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KALA | ABLV |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 39.5M |
| IPO Year | 2017 | N/A |
| Metric | KALA | ABLV |
|---|---|---|
| Price | $0.55 | $0.74 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | ★ 11.7M | 1.1M |
| Earning Date | 11-19-2025 | 01-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $114,319,869.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $0.59 |
| 52 Week High | $20.60 | $1.77 |
| Indicator | KALA | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 36.67 | 39.81 |
| Support Level | $0.57 | $0.74 |
| Resistance Level | $0.72 | $0.75 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 16.55 | 12.75 |
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.